EUVIMEDEUVIMED entdecken
VergleichsstudieÜbersichtsarbeit

Adipocytokines and Metabolic Syndrome

Yuji Matsuzawa

Seminars in Vascular Medicine · 01.01.2005 · 5 (01) · 34-39

DOI: 10.1055/s-2005-871744 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von Yuji Matsuzawa. Beteiligte Einrichtung: Sumitomo Hospital, Osaka University, Osaka, Japan. Die Arbeit wurde bisher 74-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, adipocytes have been shown to be endocrine cells that secrete a variety of bioactive substances-the so-called adipocytokines. Among adipocytokines, tumor necrotizing factor α, plasminogen activator inhibitor 1, and heparin-binding epidermal growth factor-like growth factor are produced in adipocytes as well as already known organs, and they contribute to the development of vascular diseases. Visfatin is a very recently discovered visceral fat-specific protein that may be related to the development of obesity-related diseases such as diabetes mellitus and cardiovascular disease. In contrast to these adipocytokines, adiponectin, also a newfound adipose tissue-specific collagen-like protein, has been noted recently as an important antiatherogenic as well as antidiabetic protein. The function of adipocytokine secretion might be regulated dynamically by nutritional state. Visceral fat accumulation causes dysfunction of adipocytes including oversecretion of tumor necrotizing factor α, plasminogen activator inhibitor 1, and heparin-binding epidermal growth factor-like growth factor, as well as hyposecretion of adiponectin, which results in the development of a variety of metabolic and circulatory diseases. In this review, the importance of adipocytokines, including adiponectin, is discussed with respect to atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdipocytesAdiponectinAnimalsBiomarkersCardiovascular DiseasesCase-Control StudiesFemaleHumansIntercellular Signaling Peptides and ProteinsLeptinMaleMetabolic SyndromeObesityPrognosisProspective StudiesSensitivity and SpecificityTumor Necrosis Factor-alpha

Substanzen

AdiponectinBiomarkersIntercellular Signaling Peptides and ProteinsLeptinTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Sumitomo Hospital, Osaka University, Osaka, Japan.

Zitieren

APA

Matsuzawa, Y. (2005). Adipocytokines and Metabolic Syndrome. Seminars in Vascular Medicine, 5(01), 34-39. https://doi.org/10.1055/s-2005-871744

Vancouver

Matsuzawa Y. Adipocytokines and Metabolic Syndrome. Seminars in Vascular Medicine. 2005;5(01):34-39. doi:10.1055/s-2005-871744

BibTeX
@article{Matsuzawa2005,
  author = {Matsuzawa, Yuji},
  title = {Adipocytokines and Metabolic Syndrome},
  journal = {Seminars in Vascular Medicine},
  year = {2005},
  volume = {5},
  number = {01},
  pages = {34--39},
  doi = {10.1055/s-2005-871744}
}
Kostenlos starten →